📖
Rifaximin Versus Placebo for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Alqurain AA, Abdelrahman A, Alzahib IH, Alsinan ZA, Edrissy AA, Alkhalil AO, Jamor OA, Alahmari YA, Almohmmadi OA, Alrehaili AA, Alsubhi SO, Alrawashdeh AF, Alghamdi AA, Metwaly AS

Rifaximin Versus Placebo for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Cureus.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Rifaximin Versus Placebo for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Author / Organization Alqurain AA, Abdelrahman A, Alzahib IH, Alsinan ZA, Edrissy AA, Alkhalil AO, Jamor OA, Alahmari YA, Almohmmadi OA, Alrehaili AA, Alsubhi SO, Alrawashdeh AF, Alghamdi AA, Metwaly AS
Subject & Discipline Cureus
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-8286
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »